Search results
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 3 hours agoSales of human papillomavirus vaccine Gardasil jumped 14% to $2.25 billion. That narrowly topped...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 5 hours agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 5 hours agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
20 Fastest Growing Health Tech Companies in the World
Insider Monkey via Yahoo Finance· 17 minutes agoIn this article, we will be taking a look at the 20 fastest growing health tech companies in the...
How Many More Ozempic-like Drugs Are In the Pipeline — Here’s What Researchers Are Working On
Inverse· 5 days agoA synthetic, injectable version of an intestinal hormone, it is the flagship of a new category of...
Will Higher Keytruda Sales Drive Merck's Q1
Forbes· 1 day agoMerck (NYSE: MRK) will report its Q1 2024 results on Thursday, April 25. As usual, Keytruda will be the driving growth for Merck with quarterly sales...
Merck & Co., Inc. (MRK) Scheduled to Post Quarterly Earnings on Thursday
ETF DAILY NEWS· 3 days agoMerck & Co., Inc. (NYSE:MRK – Get Free Report) will announce its earnings results before the market opens on Thursday, April 25th. Analysts expect the company to announce earnings of $2.12 per ...